Alpha Cognition is trading at $8.84, up +5.24% in after-hours trading with no confirmed company-specific catalyst.

  • No September 16, 2026 company announcement or investor event was identified.
  • The latest release, dated September 9, 2026, disclosed 25,000 inducement stock options, not earnings, FDA news, financing, or a partnership.
  • The regular-session decline was 4.55%; broader markets were mixed and biotech reportedly fell 2.11%, so sector weakness does not explain the after-hours rise.